PQIA Stock Overview
Provides outpatient diagnostic imaging services in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
RadNet, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$76.50 |
52 Week High | US$84.00 |
52 Week Low | US$29.00 |
Beta | 1.75 |
11 Month Change | 21.43% |
3 Month Change | 33.04% |
1 Year Change | 161.99% |
33 Year Change | 206.00% |
5 Year Change | 358.08% |
Change since IPO | 5,150.51% |
Recent News & Updates
Recent updates
Shareholder Returns
PQIA | DE Healthcare | DE Market | |
---|---|---|---|
7D | -6.1% | 1.0% | -0.5% |
1Y | 162.0% | 19.2% | 8.3% |
Return vs Industry: PQIA exceeded the German Healthcare industry which returned 19.2% over the past year.
Return vs Market: PQIA exceeded the German Market which returned 8.3% over the past year.
Price Volatility
PQIA volatility | |
---|---|
PQIA Average Weekly Movement | 8.2% |
Healthcare Industry Average Movement | 3.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PQIA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PQIA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 8,157 | Howard Berger | www.radnet.com |
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
RadNet, Inc. Fundamentals Summary
PQIA fundamental statistics | |
---|---|
Market cap | €5.60b |
Earnings (TTM) | -€4.19m |
Revenue (TTM) | €1.68b |
3.3x
P/S Ratio-1,335x
P/E RatioIs PQIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PQIA income statement (TTM) | |
---|---|
Revenue | US$1.77b |
Cost of Revenue | US$1.35b |
Gross Profit | US$423.02m |
Other Expenses | US$427.43m |
Earnings | -US$4.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.06 |
Gross Margin | 23.86% |
Net Profit Margin | -0.25% |
Debt/Equity Ratio | 91.1% |
How did PQIA perform over the long term?
See historical performance and comparison